Brian S. Finkelman

2.5k total citations
50 papers, 1.4k citations indexed

About

Brian S. Finkelman is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Brian S. Finkelman has authored 50 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 14 papers in Cancer Research and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Brian S. Finkelman's work include Cancer Genomics and Diagnostics (8 papers), HER2/EGFR in Cancer Research (6 papers) and Metabolism, Diabetes, and Cancer (6 papers). Brian S. Finkelman is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), HER2/EGFR in Cancer Research (6 papers) and Metabolism, Diabetes, and Cancer (6 papers). Brian S. Finkelman collaborates with scholars based in United States, Italy and Canada. Brian S. Finkelman's co-authors include Bonnie Ky, Hari K. Narayan, Matthew J. Ferrari, Bryan T. Grenfell, Cécile Viboud, Katia Koelle, Nita Bharti, Kevin Haynes, Ronac Mamtani and Stephen E. Kimmel and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Brian S. Finkelman

49 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian S. Finkelman United States 18 596 386 258 231 182 50 1.4k
Michel A. Duchosal Switzerland 25 528 0.9× 143 0.4× 479 1.9× 308 1.3× 216 1.2× 69 2.2k
Leyre Zubiri United States 22 1.3k 2.2× 268 0.7× 402 1.6× 177 0.8× 450 2.5× 56 2.0k
Mehmet Alı Nahıt Şendur Türkiye 18 825 1.4× 94 0.2× 292 1.1× 107 0.5× 446 2.5× 183 1.4k
Yuichiro Takeda Japan 20 780 1.3× 145 0.4× 387 1.5× 152 0.7× 629 3.5× 123 1.6k
Ehab Atallah United States 24 564 0.9× 110 0.3× 649 2.5× 101 0.4× 137 0.8× 175 2.1k
Fabienne Thomas France 26 829 1.4× 50 0.1× 516 2.0× 339 1.5× 332 1.8× 109 2.0k
Edward N. Libby United States 22 1.1k 1.9× 281 0.7× 1.1k 4.3× 81 0.4× 92 0.5× 87 2.5k
Ishmael Jaiyesimi United States 21 1.3k 2.2× 168 0.4× 632 2.4× 200 0.9× 784 4.3× 119 3.1k
Sujatha Menon United States 22 702 1.2× 69 0.2× 324 1.3× 384 1.7× 98 0.5× 55 3.6k
Vivien Chen Australia 23 302 0.5× 269 0.7× 382 1.5× 127 0.5× 279 1.5× 93 2.0k

Countries citing papers authored by Brian S. Finkelman

Since Specialization
Citations

This map shows the geographic impact of Brian S. Finkelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian S. Finkelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian S. Finkelman more than expected).

Fields of papers citing papers by Brian S. Finkelman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian S. Finkelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian S. Finkelman. The network helps show where Brian S. Finkelman may publish in the future.

Co-authorship network of co-authors of Brian S. Finkelman

This figure shows the co-authorship network connecting the top 25 collaborators of Brian S. Finkelman. A scholar is included among the top collaborators of Brian S. Finkelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian S. Finkelman. Brian S. Finkelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Finkelman, Brian S., et al.. (2025). Tumor infiltrating lymphocytes in breast cancer: A narrative review with focus on analytic validity, clinical validity, and clinical utility. Human Pathology. 162. 105866–105866. 3 indexed citations
2.
Finkelman, Brian S., Jessica C. Gooch, Kristin A. Skinner, et al.. (2025). Real-World Application of Alliance ACOSOG Z11102: How Many Patients Can be Spared Mastectomy?. Annals of Surgical Oncology. 32(11). 8271–8279.
3.
Zhang, Huina, et al.. (2024). HER2 evaluation for clinical decision making in human solid tumours: pearls and pitfalls. Histopathology. 85(1). 3–19. 12 indexed citations
4.
Finkelman, Brian S., Bradley M. Turner, Ioana Moisini, et al.. (2024). Performance of HER2 DAKO HercepTest and Ventana 4B5 immunohistochemical assays on detecting HER2 gene-amplification in uterine serous carcinomas. Human Pathology. 148. 51–59. 2 indexed citations
5.
Finkelman, Brian S., Bradley M. Turner, Xi Wang, et al.. (2023). HER2 in uterine serous carcinoma: Current state and clinical perspectives. American Journal of Clinical Pathology. 160(4). 341–351. 4 indexed citations
6.
7.
Finkelman, Brian S., Huina Zhang, David G. Hicks, & Bradley M. Turner. (2023). The Evolution of Ki-67 and Breast Carcinoma: Past Observations, Present Directions, and Future Considerations. Cancers. 15(3). 808–808. 34 indexed citations
8.
9.
Shah, Ami N., Brian S. Finkelman, Andrew A. Davis, et al.. (2022). Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers. Oncotarget. 13(1). 273–280. 5 indexed citations
10.
11.
Alexiev, Borislav A., Brian S. Finkelman, Melissa Mejía-Bautista, et al.. (2021). Solitary fibrous tumor of thoracic cavity, extra-thoracic sites and central nervous system: Clinicopathologic features and association with local recurrence and metastasis. Pathology - Research and Practice. 224. 153531–153531. 5 indexed citations
12.
Finkelman, Brian S., et al.. (2020). The diagnostic utility of PRAME and p16 in distinguishing nodal nevi from nodal metastatic melanoma. Pathology - Research and Practice. 216(9). 153105–153105. 33 indexed citations
13.
Alexiev, Borislav A., Daniel N. Johnson, Brian S. Finkelman, et al.. (2020). Oropharyngeal carcinoma: A single institution study of 338 primaries with special reference to high-risk human papillomavirus-mediated carcinoma with aggressive behavior. Pathology - Research and Practice. 216(12). 153243–153243. 6 indexed citations
14.
Upshaw, Jenica, Brian S. Finkelman, Rebecca A. Hubbard, et al.. (2019). Comprehensive Assessment of Changes in Left Ventricular Diastolic Function With Contemporary Breast Cancer Therapy. JACC. Cardiovascular imaging. 13(1). 198–210. 83 indexed citations
15.
Upshaw, Jenica, Brian S. Finkelman, Rebecca A. Hubbard, et al.. (2019). CHANGES IN LEFT VENTRICULAR DIASTOLIC FUNCTION WITH CONTEMPORARY BREAST CANCER THERAPY. Journal of the American College of Cardiology. 73(9). 1676–1676. 1 indexed citations
16.
Zhang, Kathleen W., Brian S. Finkelman, Gaurav Gulati, et al.. (2018). Abnormalities in 3-Dimensional Left Ventricular Mechanics With Anthracycline Chemotherapy Are Associated With Systolic and Diastolic Dysfunction. JACC. Cardiovascular imaging. 11(8). 1059–1068. 53 indexed citations
17.
Narayan, Vivek, Stephen J. O’Keefe, Naomi B. Haas, et al.. (2017). Prospective Evaluation of Sunitinib-Induced Cardiotoxicity in Patients with Metastatic Renal Cell Carcinoma. Clinical Cancer Research. 23(14). 3601–3609. 58 indexed citations
18.
Finkelman, Brian S., Mary Putt, Hari K. Narayan, et al.. (2017). Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast Cancer. Journal of the American College of Cardiology. 70(2). 152–162. 87 indexed citations
19.
Boursi, Ben, Brian S. Finkelman, Bruce J. Giantonio, et al.. (2016). A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes. Gastroenterology. 152(4). 840–850.e3. 136 indexed citations
20.
Finkelman, Brian S., et al.. (2014). Factors affecting time to maintenance dose in patients initiating warfarin. Pharmacoepidemiology and Drug Safety. 24(3). 228–236. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michel A. Duchosal Breakdown of academic impact, for papers by Leyre Zubiri Breakdown of academic impact, for papers by Mehmet Alı Nahıt Şendur Breakdown of academic impact, for papers by Yuichiro Takeda Breakdown of academic impact, for papers by Ehab Atallah Breakdown of academic impact, for papers by Fabienne Thomas Breakdown of academic impact, for papers by Edward N. Libby Breakdown of academic impact, for papers by Ishmael Jaiyesimi Breakdown of academic impact, for papers by Sujatha Menon Breakdown of academic impact, for papers by Vivien Chen
Rankless by CCL
2026